A component manufacturer supplies goods that may become part of a much more valuable finished product. Insurance comparison should address the component’s use, contractual responsibilities and the consequences of failure after integration.
Products and supply-chain responsibility
Product liability and product recall should be assessed separately. Claims concerning injury or damage, replacing defective goods and organising a withdrawal can have different triggers and exclusions. Describe the business’s role in the supply chain.
Premiums, excesses and usable cover
Request quotations using the same business description, required limits and relevant dates. Put the annual premium, any instalment charges, excesses and important sublimits in one comparison. A cheaper premium can represent a different transfer of risk rather than the same cover at a better price.
| Comparison item | Question to resolve |
|---|---|
| End uses and safety-critical applications | Which customer industries are accepted? |
| Contractual warranties and indemnities | Are pure financial losses treated separately? |
| Traceability and consequences of integrated failure | How are replacement and recall costs excluded or insured? |
Request the proposed wording and schedule, not just a price or certificate. Mark any difference that affects a real activity before deciding whether the premium saving is worthwhile.
The decision that deserves the closest review
Identify customer industries and whether products are safety-critical. Ask how damage to other property, replacement of the component and wider recall expenses are distinguished. Compare liability assumed under supply agreements with the responsibilities accepted by the insurer.
Prepare an accurate insurance enquiry
Give each adviser a consistent description of the activities being insured. Include important contracts, changes since the previous enquiry and matters the insurer asks you to disclose. Do not guess answers merely to obtain a faster or cheaper quote; ask for clarification when the proposal wording is unclear.
Explain what the component does in the finished product
Describe the component’s intended uses and the customers who integrate it. Include specifications, testing arrangements and any commitments about performance. This gives advisers a clearer basis for distinguishing a physical-damage allegation from a customer’s claim about redesign, replacement or lost production.
Use a representative supply contract to compare exclusions and accepted uses. Ask how proposals address goods incorporated into another product and liabilities voluntarily accepted in the contract. Keep changes in application visible: a component approved for one use should not silently become the basis for a different insurance enquiry.
Include overseas work or sales in the UK business’s enquiry and confirm the accepted territories and jurisdictions.
A hypothetical example
A small component causes a customer to stop production while investigating a defect. The manufacturer asks about physical damage, pure financial loss and recall-related expenses separately rather than treating every customer cost as insured.
A mistake to avoid
Focusing on component selling price rather than the potential exposure created by its end use.
Check what happens after the policy starts
Ask who to contact when activities change or a potential claim arises. Understand the notification and consent process before arranging repairs, appointing specialists or settling a complaint. At renewal, compare the new documents with the accepted business description; continuity of a familiar brand does not prove continuity of every term.
Questions before choosing
Does a product guarantee provide insurance cover?
A commercial guarantee and an insurance contract are different; disclose unusual commitments before accepting them.
Should the manufacturer disclose the customer’s end use?
Provide relevant information requested by the adviser. The same component can create different questions depending on where it is installed and what the customer expects it to do.
Sources and further reading
Research date: 6 October 2026. Refer to the current linked guidance and written provider or adviser terms when making a decision.